Return to search

Pevion Raises Series A

Pevion Biotech Ltd., a Swiss developer of prophylactic and therapeutic vaccines, has raised CHF 35 million ($29.16m) in “Series A” funding. BZ Bank Aktiengesellschaft led the deal, and was joined by BB Biotech Ventures, CC Private Equity Partners and return backer Bachem Holding AG. Pevion has now raised a total of CHF 55 million.